Covid-19 Research

Research Article

Initial Clinical Experience with New Technology ePatchTM Extended Holter Monitoring

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Research Article
Subject Medicine Group
OCLC JBRES Record
Pedro Blanch*, Antonia Ortega, Sandra Escura, Manuel Gomez-Choco, Miquel Barras and Roman Freixa-Pamias
Issue: Volume5-Issue2
Pages: 152-158
Received: 2024-02-10
Accepted: 2024-02-21
Published: 2024-02-26

Abstract

Introduction and objectives: Conventional methods of Holter (H) monitoring, data analysis and reporting can be inefficient, leading to high costs and long response times. Traditional H devices can be cumbersome to wear, and uncomfortable testing can reduce patient compliance and satisfaction, impacting diagnostic performance. This new device ePatchTM is a simple application of patch and activation without the need to charge the battery and without connecting cables (Figure 1). Up to 14 days of continuous Electrocardiogram (ECG) recording. It can be worn in the shower and during exercise. Single channel, up to 14 days. Two channels, up to 7 days. Our objective is to evaluate the quality and diagnostic efficacy of ePatchTM in different clinical settings.

Methods: Prospective study of patients with ePatchTM placed in our centre requested for the study of undocumented palpitations, syncope or cryptogenic stroke. Clinical variables, diagnostic accuracy and time to diagnostic event are analysed.

Results: The first 154 patients were included, of whom (51.3%) were women, with a mean age of 66.6 years (range 18 to 89). The most frequent indication was palpitations (37%) followed by cryptogenic stroke (34.4%), followed by syncope (28.5%). All patients had correct compliance and tolerance and the monitored ECG was of good quality. A conclusive diagnosis: (sustained symptomatic tachyarrhythmia, atrioventricular block with bradyarrhythmia, significant pauses or atrial fibrillation) was obtained in 15 patients (9.7% of the total). 14-, 7-, and 5-day recorders were used. The median event time since ePatchTM logging began was 2.6 days (range 1 to 5 days). Only the duration of H (OR 10.6), and left atrial dilation (OR 5) were significant predictors of arrhythmic event in the multivariate analysis.

Conclusion: ePatchTM is a new H device that offers a simple, complete and effective ECG monitoring system. This new technology is safe and has numerous advantages: spending less time on device logistics and handling, preparing patients efficiently, eliminating the need for additional consumables, and constantly replacing the battery. The ECG monitor can be used for up to 14 days. It is designed to address the challenges of traditional H monitoring.

FullText HTML FullText PDF DOI: 10.37871/jbres1882 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Blanch P, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Blanch P, Ortega A, Escura S, Gomez-Choco M, Barras M, Freixa-Pamias R. Initial Clinical Experience with New Technology: ePatchTM Extended Holter Monitoring. J Biomed Res Environ Sci. 2024 Feb 25; 5(2): 152-158. doi: 10.37871/jbres1882, Article ID: JBRES1882, Available at: https://www.jelsciences.com/articles/jbres1882.pdf

Subject area(s)

Cardiovascular DiseasesClinical Cardiology

References

  1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546-547. Erratum in: Eur Heart J. 2021 Oct 21;42(40):4194. PMID: 32860505.
  2. Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Grubb BP, Hamdan MH, Krahn AD, Link MS, Olshansky B, Raj SR, Sandhu RK, Sorajja D, Sun BC, Yancy CW. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017 Aug 1;136(5):e60-e122. doi: 10.1161/CIR.0000000000000499. Epub 2017 Mar 9. Erratum in: Circulation. 2017 Oct 17;136(16):e271-e272. PMID: 28280231.
  3. Sana F, Isselbacher EM, Singh JP, Heist EK, Pathik B, Armoundas AA. Wearable Devices for Ambulatory Cardiac Monitoring: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Apr 7;75(13):1582-1592. doi: 10.1016/j.jacc.2020.01.046. PMID: 32241375; PMCID: PMC7316129.
  4. Pitman BM, Chew SH, Wong CX, Jaghoori A, Iwai S, Thomas G, Chew A, Sanders P, Lau DH. Performance of a Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Screening in a Semirural African Population: Insights From "The Heart of Ethiopia: Focus on Atrial Fibrillation" (TEFF-AF) Study. JMIR Mhealth Uhealth. 2021 May 19;9(5):e24470. doi: 10.2196/24470. PMID: 34009129; PMCID: PMC8173399.
  5. Liu CM, Chang SL, Yeh YH, Chung FP, Hu YF, Chou CC, Hung KC, Chang PC, Liao JN, Chan YH, Lo LW, Wu LS, Lin YJ, Wen MS, Chen SA. Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring. Int J Cardiol. 2021 Jun 1;332:78-84. doi: 10.1016/j.ijcard.2021.03.015. Epub 2021 Mar 13. PMID: 33727122.
  6. Heckbert SR, Austin TR, Jensen PN, Floyd JS, Psaty BM, Soliman EZ, Kronmal RA. Yield and consistency of arrhythmia detection with patch electrocardiographic monitoring: The Multi-Ethnic Study of Atherosclerosis. J Electrocardiol. 2018 Nov-Dec;51(6):997-1002. doi: 10.1016/j.jelectrocard.2018.07.027. Epub 2018 Jul 30. PMID: 30497763; PMCID: PMC6278608.
  7. Giebel GD, Gissel C. Accuracy of mHealth Devices for Atrial Fibrillation Screening: Systematic Review. JMIR Mhealth Uhealth. 2019 Jun 16;7(6):e13641. doi: 10.2196/13641. PMID: 31199337; PMCID: PMC6598422.
  8. Kwon S, Lee SR, Choi EK, Ahn HJ, Song HS, Lee YS, Oh S. Validation of Adhesive Single-Lead ECG Device Compared with Holter Monitoring among Non-Atrial Fibrillation Patients. Sensors (Basel). 2021 Apr 30;21(9):3122. doi: 10.3390/s21093122. PMID: 33946269; PMCID: PMC8124998.
  9. Bansal A, Joshi R. Portable out-of-hospital electrocardiography: A review of current technologies. J Arrhythm. 2018 Feb 23;34(2):129-138. doi: 10.1002/joa3.12035. PMID: 29657588; PMCID: PMC5891427.
  10. Steinhubl SR, Waalen J, Edwards AM, Ariniello LM, Mehta RR, Ebner GS, Carter C, Baca-Motes K, Felicione E, Sarich T, Topol EJ. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial. JAMA. 2018 Jul 10;320(2):146-155. doi: 10.1001/jama.2018.8102. PMID: 29998336; PMCID: PMC6583518.
  11. Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez MV, Freeman JV, Wang PJ, Heidenreich PA. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015 May;38(5):285-92. doi: 10.1002/clc.22387. Epub 2015 Apr 14. PMID: 25873476; PMCID: PMC4654330.
  12. Pagola J, Juega J, Francisco-Pascual J, Moya A, Sanchis M, Bustamante A, Penalba A, Usero M, Cortijo E, Arenillas JF, Calleja AI, Sandin-Fuentes M, Rubio J, Mancha F, Escudero-Martinez I, Moniche F, de Torres R, Pérez-Sánchez S, González-Matos CE, Vega Á, Pedrote AA, Arana-Rueda E, Montaner J, Molina CA; CryptoAF investigators. Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry. Int J Cardiol. 2018 Jan 15;251:45-50. doi: 10.1016/j.ijcard.2017.10.063. Epub 2017 Oct 22. PMID: 29107360.
  13. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, Reinhardt R, Hepp T, Kirchhof P, Aleynichenko E, Ringleb P, Hacke W, Veltkamp R. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012 Oct;43(10):2689-94. doi: 10.1161/STROKEAHA.112.654954. Epub 2012 Aug 7. PMID: 22871678..
  14. Sorgente A, Tung P, Wylie J, Josephson ME. Six year follow-up after catheter ablation of atrial fibrillation: a palliation more than a true cure. Am J Cardiol. 2012 Apr 15;109(8):1179-86. doi: 10.1016/j.amjcard.2011.11.058. Epub 2012 Jan 14. PMID: 22245414.
  15. Passman R, Bernstein RA. New Appraisal of Atrial Fibrillation Burden and Stroke Prevention. Stroke. 2016 Feb;47(2):570-6. doi: 10.1161/STROKEAHA.115.009930. Epub 2016 Jan 5. PMID: 26732565.
  16. Chiang CE, Wu TJ, Ueng KC, Chao TF, Chang KC, Wang CC, Lin YJ, Yin WH, Kuo JY, Lin WS, Tsai CT, Liu YB, Lee KT, Lin LJ, Lin LY, Wang KL, Chen YJ, Chen MC, Cheng CC, Wen MS, Chen WJ, Chen JH, Lai WT, Chiou CW, Lin JL, Yeh SJ, Chen SA. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. J Formos Med Assoc. 2016 Nov;115(11):893-952. doi: 10.1016/j.jfma.2016.10.005. Epub 2016 Nov 24. PMID: 27890386.
  17. Arenillas J, Rubio J, Carneado-Ruiz J, Toquero J, Lobato P, Pachón M, Palacio E, Rodríguez F, Ponz A, Ruiz R, Quirós R, Alonso de Leciñana M. Recomendaciones para la monitorización cardiaca en pacientes con ictus criptogénico. Sociedad Española de Neurología. Sociedad Española de Cardiología. Consensus Document. 2019.
  18. Health Quality Ontario. Long-Term Continuous Ambulatory ECG Monitors and External Cardiac Loop Recorders for Cardiac Arrhythmia: A Health Technology Assessment. Ont Health Technol Assess Ser. 2017 Jan 31;17(1):1-56. PMID: 28194254; PMCID: PMC5300052.
  19. Chua SK, Chen LC, Lien LM, Lo HM, Liao ZY, Chao SP, Chuang CY, Chiu CZ. Comparison of Arrhythmia Detection by 24-Hour Holter and 14-Day Continuous Electrocardiography Patch Monitoring. Acta Cardiol Sin. 2020 May;36(3):251-259. doi: 10.6515/ACS.202005_36(3).20190903A. PMID: 32425440; PMCID: PMC7220965.
  20. Karunadas CP, Mathew C. Comparison of arrhythmia detection by conventional Holter and a novel ambulatory ECG system using patch and Android App, over 24 h period. Indian Pacing Electrophysiol J. 2020 Mar-Apr;20(2):49-53. doi: 10.1016/j.ipej.2019.12.013. Epub 2019 Dec 19. PMID: 31866554; PMCID: PMC7082686.
  21. Kwon S, Lee SR, Choi EK, Ahn HJ, Song HS, Lee YS, Oh S, Lip GYH. Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study. J Med Internet Res. 2022 May 9;24(5):e37970. doi: 10.2196/37970. PMID: 35532989; PMCID: PMC9127648.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership